Please assess the completion status of the following clinical trial:

Trial Title: TMS Augmented Exposure Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Criteria for a simple phobia: specific heights~Exclusion Criteria:~Objective tinnitus Involvement in psychiatric treatments Clinically relevant psychiatric comorbidity Clinically relevant unstable internal or neurological comorbidity History of or evidence of significant brain malformation or neoplasm, head injury Cerebral vascular events Neurodegenerative disorder affecting the brain or prior brain surgery Metal objects in and around body that can not be removed Pregnancy Alcohol or drug abuse history of seizures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Verum transcranial magnetic stimulation (TMS) (Type: EXPERIMENTAL): 10 Hz TMS over medial prefrontal cortex
- Sham transcranial magnetic stimulation (TMS) (Type: EXPERIMENTAL): 10 Hz sham TMS over medial prefrontal cortex

Based on this trial design, predict the completion outcome and termination type (if applicable).